Ariel Rubashkin

Ariel Rubashkin

Director/Board Member presso ENDYMED LTD

45 anni
Health Technology
Consumer Services
Finance

Profilo

Ariel Rubashkin is an Independent Director at EndyMed Ltd.
and a Managing Director at Syneron GmbH.
He is also a Director at Allium Ltd., Truleaf Medical Ltd., and Allevetix Medical Ltd.
Mr. Rubashkin was previously the Chief Executive Officer at Allmed Solutions Ltd.
from 2014 to 2022 and the Global Vice President-Finance at Syneron Medical Ltd.
from 2007 to 2014.
He also worked as a Controller at Plastro Gvat.
Mr. Rubashkin holds an MBA from Tel-Aviv University and an undergraduate degree from the University of Haifa.

Posizioni attive di Ariel Rubashkin

SocietàPosizioneInizio
ENDYMED LTD Director/Board Member 05/01/2021
Chief Executive Officer 19/10/2011
Allevetix Medical Ltd. Director/Board Member 01/10/2019
Truleaf Medical Ltd. Director/Board Member 01/10/2019
Allium Ltd. Director/Board Member 01/10/2019
Tutte le posizioni attive di Ariel Rubashkin

Precedenti posizioni note di Ariel Rubashkin

SocietàPosizioneFine
ALLMED SOLUTIONS LTD Chief Executive Officer 28/02/2022
SYNERON MEDICAL LTD. Corporate Officer/Principal 01/01/2014
Comptroller/Controller/Auditor 02/01/1990
Vedi nel dettaglio l'esperienza di Ariel Rubashkin

Formazione di Ariel Rubashkin

Tel-Aviv University Masters Business Admin
University of Haifa Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ariel Rubashkin

Relazioni

100 +

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
ENDYMED LTD

Health Technology

ALLMED SOLUTIONS LTD

Health Technology

Aziende private6

Health Technology

Allium Ltd.

Finance

Truleaf Medical Ltd.

Allevetix Medical Ltd.

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Ariel Rubashkin